Marker Therapeutics, Inc.
MRKR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11 | -$14 | -$20 | -$42 |
| Dep. & Amort. | $0 | $0 | $0 | $3 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $1 | $0 | $6 |
| Change in WC | -$0 | $3 | -$5 | $5 |
| Other Non-Cash | $0 | -$6 | -$2 | $0 |
| Operating Cash Flow | -$11 | -$16 | -$27 | -$27 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $19 | -$5 | $0 |
| Investing Cash Flow | $0 | $19 | -$5 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $15 | $1 | $0 | $53 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $15 | $1 | $0 | $53 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4 | $3 | -$32 | $22 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15 | $12 | $43 | $21 |
| End Cash | $19 | $15 | $12 | $43 |
| Free Cash Flow | -$11 | -$16 | -$27 | -$30 |